New drug given during breast cancer surgery shows early promise
NCT ID NCT06300411
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tested a new drug called SRG-514 in 25 people undergoing breast-conserving surgery for breast cancer. The drug was given directly into the area where the tumor was removed. The main goal was to find a safe dose and check for side effects. This is a first step to see if the approach might help control breast cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SRG-514 (a drug containing ketorolac)
What this could lead to
If it works, this could lead to a new treatment given during breast cancer surgery to help control the disease.
What could go wrong
This is a very early, small phase 1 trial focused on safety, not effectiveness. It may not show benefit or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Audie Murphy VA
San Antonio, Texas, 78229, United States
-
Duke Cancer Center
Durham, North Carolina, 27710, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo
Rochester, Minnesota, 55905, United States
-
Memorial Health
Savannah, Georgia, 31404, United States
-
NYU Langone Health
New York, New York, 10016, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States